Tag: Johnson & Johnson
October 16, 2018
Pharmaceutical Update: Q3 2018 in Review
With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some... October 16, 2018
Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2018
Genmab (Nasdaq:GEN) announced today that worldwide net sales of DARZALEX (daratumumab) as reported by Johnson & Johnson were USD 498...
September 27, 2018
Geron Cancels Janssen Collaboration, Share Price Drops
Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different...
September 19, 2018
9 Glucose Monitoring Device Stocks
Demand for glucose monitoring devices with the most advanced technology is growing as the number of diabetic patients increases. Here...
September 17, 2018
Investing in Glucose Monitoring Devices
Diabetes is one of the 10 top killers around the world, and as the healthcare industry races to accommodate growing demand... June 7, 2018
Fortive Announces Binding Offer to Acquire the Advanced Sterilization Products Business from Johnson & Johnson
Fortive (NYSE: FTV) announced today that it has made a binding offer to Ethicon, a subsidiary of Johnson & Johnson,...
December 21, 2017